ScinoPharm Taiwan Ltd (1789) — Capital Reinvestment Ratio
Latest as of March 2026:
0.42x
ScinoPharm Taiwan Ltd (1789) has a Capital Reinvestment Ratio of 0.42x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$199.47 Million) in capital expenditures (NT$83.34 Million). See cash generation quality of ScinoPharm Taiwan Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.42x
Capex / Operating Cash Flow
Operating Cash Flow
NT$199.47 Million
TWD
Capital Expenditures
NT$83.34 Million
TWD
Data as of
Mar 2026
Most recent filing
ScinoPharm Taiwan Ltd Capital Reinvestment Ratio (2007–2025)
This chart tracks ScinoPharm Taiwan Ltd's Capital Reinvestment Ratio across 19 annual periods.
Annual Capital Reinvestment Ratio for ScinoPharm Taiwan Ltd (2007–2025)
Year-by-year Capital Reinvestment Ratio for ScinoPharm Taiwan Ltd from 2007 to 2025. For live market cap and broader valuation context, see ScinoPharm Taiwan Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.49x | NT$597.11 Million | NT$291.29 Million | ▲ +26.9% |
| 2024 | 0.38x | NT$750.91 Million | NT$288.73 Million | ▼ -68.8% |
| 2023 | 1.23x | NT$231.13 Million | NT$284.71 Million | ▲ +281.2% |
| 2022 | 0.32x | NT$773.79 Million | NT$250.04 Million | ▼ -48.7% |
| 2021 | 0.63x | NT$509.82 Million | NT$321.32 Million | ▲ +225.7% |
| 2020 | 0.19x | NT$946.31 Million | NT$183.10 Million | ▲ +44.4% |
| 2019 | 0.13x | NT$788.95 Million | NT$105.70 Million | ▲ +29.9% |
| 2018 | 0.10x | NT$1.23 Billion | NT$127.05 Million | ▼ -75.6% |
| 2017 | 0.42x | NT$971.71 Million | NT$410.93 Million | ▲ +53.6% |
| 2016 | 0.28x | NT$1.67 Billion | NT$458.52 Million | ▼ -56.9% |
| 2015 | 0.64x | NT$1.04 Billion | NT$667.58 Million | ▼ -44.5% |
| 2014 | 1.15x | NT$888.29 Million | NT$1.02 Billion | ▼ -13.0% |
| 2013 | 1.32x | NT$939.47 Million | NT$1.24 Billion | ▲ +47.5% |
| 2012 | 0.90x | NT$981.55 Million | NT$881.19 Million | ▲ +43.4% |
| 2011 | 0.63x | NT$1.29 Billion | NT$810.14 Million | ▲ +141.4% |
| 2010 | 0.26x | NT$1.56 Billion | NT$405.62 Million | ▲ +75.9% |
| 2009 | 0.15x | NT$1.30 Billion | NT$191.28 Million | ▲ +43.4% |
| 2008 | 0.10x | NT$1.41 Billion | NT$144.62 Million | ▼ -37.3% |
| 2007 | 0.16x | NT$504.50 Million | NT$82.74 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow